The clinical effectiveness and cost-effectiveness of gemcitabine for metastatic breast cancer: a systematic review and economic evaluation

Journal: Health Technology Assessment • • NIHR Journals Library • ISSN: 1366-5278

Abstract

Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.

Subjects & Keywords

How to Cite this Article

A Takeda, J Jones, E Loveman, et al. (2007). "The clinical effectiveness and cost-effectiveness of gemcitabine for metastatic breast cancer: a systematic review and economic evaluation". Health Technology Assessment. https://doi.org/10.3310/hta11190